Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Pashamylaram, Hyderabad. The facility was inspected from February 3, 2020 to February 7, 2020. The inspection has now been closed by the USFDA.
Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.
